Bank of America’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
VCM
VPM
N
Bank of America's ALT Position: Q1 2026 in Review
Bank of America increased its Altimmune (ALT) stake by 49% in Q1 2026, buying an estimated $792K and bringing the position to 570,203 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4201.
Bank of America first reported a position in ALT in Q2 2014 and has held it in 39 quarters since. The position peaked at $8.71M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Bank of America held 570,203 shares of Altimmune worth $1.76M as of Q1 2026.
- Bank of America bought 186,420 Altimmune shares in Q1 2026, an estimated $792K.
- Altimmune made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4201 holding.
- Bank of America first reported a position in Altimmune in Q2 2014 and has held it in 39 quarters since.
- Bank of America's Altimmune position peaked at $8.71M in Q4 2022.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.